Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 ...
Even as President Donald Trump wages a very public fight against diversity, equity and inclusion (DEI) initiatives in the ...
The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback